Product Description for DBI / ACBP
DBI / ACBP.
Presentation: Purified
Presentation: Purified
Properties for DBI / ACBP
| Product Category | Proteins |
|---|---|
| Quantity | 0.1 mg |
| Synonyms | Acyl-CoA-binding protein, Diazepam-binding inhibitor, Endozepine |
| Presentation | Purified |
| Reactivity | Hu |
| Molecular weight | 12.2 kDa |
| Species (Protein) | Human |
| Shipping to | Not USA/Canada |
| PDF datasheet | View Datasheet |
| Manufacturer | Novus Biologicals Inc. |
Datasheet Extract
| Immunogen |
|
|---|---|
| Background | ACBP, also known as ACBD1, is a diazepam binding inhibitor, a protein that is regulated by hormones and is involved in lipid metabolism and the displacement of beta-carbolines and benzodiazepines, which modulate signal transduction at type A gamma-aminobutyric acid receptors located in brain synapses. Expression of ACBP is significantly induced during adipocyte differentiation. ACBP is a target for proliferator-activated receptor (PPAR)', and is directly activated by PPAR'/RXR' and PPAR'/RXR', but not by PPAR'/RXR'. Recombinant human ACBP protein, fused to His-tag at N-terminus, was expressed in E.coli and purified by using conventional chromatography techniques. |
| Concentration | 1 mg/ml |
| Storage | Store at -80C. Avoid freeze-thaw cycles. |
| Format |
|
| Targets |
Accessory Products
Proteins and/or Positive Controls
Proteins for DBI / ACBP (7 products)
| Catalog No. | Species | Pres. | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| AR09477PU-L |
DBI / ACBP (1-87, His-tag) |
||||||
![]() |
Human | Purified | > 95 % | E. coli |
0.5 mg /
€670.00
|
||
| Acris Antibodies GmbH | |||||||
| AR09477PU-N |
DBI / ACBP (1-87, His-tag) |
||||||
![]() |
Human | Purified | > 95 % | E. coli |
0.1 mg /
€250.00
|
||
| Acris Antibodies GmbH | |||||||
| H00001622-P01-10 |
DBI / ACBP |
||||||
![]() |
Human | Purified |
10 µg /
€350.00
|
||||
| Abnova Taiwan Corp. | |||||||
| H00001622-P01-25 |
DBI / ACBP |
||||||
![]() |
Human | Purified |
25 µg /
€500.00
|
||||
| Abnova Taiwan Corp. | |||||||
| H00001622-Q01-10 |
DBI / ACBP |
||||||
![]() |
Human | in vitro transl. |
10 µg /
€350.00
|
||||
| Abnova Taiwan Corp. | |||||||
| H00001622-Q01-25 |
DBI / ACBP |
||||||
![]() |
Human | in vitro transl. |
25 µg /
€500.00
|
||||
| Abnova Taiwan Corp. | |||||||
| LF-P0046 |
DBI / ACBP |
||||||
![]() |
Human | > 95 % | E. coli |
0.5 mg /
€210.00
|
|||
| Young In Frontier Co. Ltd. | |||||||
Positive controls for DBI / ACBP (1 products)
| Catalog No. | Species | Pres. | Purity | Source | |||
|---|---|---|---|---|---|---|---|
| NBL1-09728 |
Diazepam Binding Inhibitor Lysate |
||||||
![]() |
0.1 mg /
€370.00
|
||||||
| Novus Biologicals Inc. | |||||||



![Western Blot: Diazepam Binding Inhibitor Lysate [NBL1-09728] - Western Blot experiments.
Left-Control; Right -Over-expression Lysate for DBI](http://m1.acris-antibodies.com/catalog/product/cache/1/small_image/50x50/9df78eab33525d08d6e5fb8d27136e95/Novus/Diazepam Binding Inhibitor Lysate-Western Blot-NBL1-09728-img0001.jpg)




